Antibody-Based Targeting of Cell Surface GRP94 Specifically Inhibits Cetuximab-Resistant Colorectal Cancer Growth.
Jeoung, Mee Hyun
Antibody-Based Targeting of Cell Surface GRP94 Specifically Inhibits Cetuximab-Resistant Colorectal Cancer Growth. [electronic resource] - Biomolecules 11 2019
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2218-273X
10.3390/biom9110681 doi
Animals
Antibodies, Monoclonal, Humanized--administration & dosage
Antineoplastic Agents, Immunological--administration & dosage
Cell Proliferation--drug effects
Cetuximab--administration & dosage
Colorectal Neoplasms--drug therapy
Drug Resistance, Neoplasm
HCT116 Cells
HSP70 Heat-Shock Proteins--genetics
Humans
Membrane Proteins--genetics
Mice
Mice, Inbred BALB C
Antibody-Based Targeting of Cell Surface GRP94 Specifically Inhibits Cetuximab-Resistant Colorectal Cancer Growth. [electronic resource] - Biomolecules 11 2019
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2218-273X
10.3390/biom9110681 doi
Animals
Antibodies, Monoclonal, Humanized--administration & dosage
Antineoplastic Agents, Immunological--administration & dosage
Cell Proliferation--drug effects
Cetuximab--administration & dosage
Colorectal Neoplasms--drug therapy
Drug Resistance, Neoplasm
HCT116 Cells
HSP70 Heat-Shock Proteins--genetics
Humans
Membrane Proteins--genetics
Mice
Mice, Inbred BALB C